Current Developments in Sustainability Assurance: Impact of Emerging Regulations
Current Issues in Auditing · 01.11.2026 · 20 (2) · A14-A26
DOI: 10.2308/ciia-2024-038 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Issues in Auditing, online erschienen am 20.10.2026. Verfasst von Stephen H. Fuller und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
Over the past three decades, the practice of voluntarily obtaining independent assurance for sustainability disclosures has grown significantly. We are now on the verge of a monumental shift in sustainability assurance due to emerging mandatory assurance requirements introduced by the Securities and Exchange Commission (SEC) adopting rules to standardize climate-related disclosures, the state of California passing three climate disclosure bills (SB253, SB261, and AB1305), and the EU passing the Corporate Sustainability Reporting Directive. This paper provides an overview of the three regulations, including their current implementation status; identifies four key elements of the sustainability assurance requirements within them; and discusses the challenges and implications for practice. JEL Classifications: M420; M490.
Zitieren
APA
Fuller, S. H., Heron, N. M., Riley, T. J., & Stuart, A. C. (2026). Current Developments in Sustainability Assurance: Impact of Emerging Regulations. Current Issues in Auditing, 20(2), A14-A26. https://doi.org/10.2308/ciia-2024-038
Vancouver
Fuller SH, Heron NM, Riley TJ, Stuart AC. Current Developments in Sustainability Assurance: Impact of Emerging Regulations. Current Issues in Auditing. 2026;20(2):A14-A26. doi:10.2308/ciia-2024-038
BibTeX
@article{Fuller2026,
author = {Fuller, Stephen H. and Heron, Nicole M. and Riley, Tracey J. and Stuart, Andrew C.},
title = {Current Developments in Sustainability Assurance: Impact of Emerging Regulations},
journal = {Current Issues in Auditing},
year = {2026},
volume = {20},
number = {2},
pages = {A14--A26},
doi = {10.2308/ciia-2024-038}
}
EUVIMED